1. Home
  2. BCBP vs CRBP Comparison

BCBP vs CRBP Comparison

Compare BCBP & CRBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BCB Bancorp Inc. (NJ)

BCBP

BCB Bancorp Inc. (NJ)

HOLD

Current Price

$8.31

Market Cap

146.0M

Sector

Finance

ML Signal

HOLD

Logo Corbus Pharmaceuticals Holdings Inc.

CRBP

Corbus Pharmaceuticals Holdings Inc.

HOLD

Current Price

$8.51

Market Cap

134.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCBP
CRBP
Founded
2000
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
146.0M
134.8M
IPO Year
2005
2014

Fundamental Metrics

Financial Performance
Metric
BCBP
CRBP
Price
$8.31
$8.51
Analyst Decision
Hold
Strong Buy
Analyst Count
2
7
Target Price
$9.00
$46.17
AVG Volume (30 Days)
83.8K
144.9K
Earning Date
05-01-2026
01-01-0001
Dividend Yield
3.94%
N/A
EPS Growth
N/A
64.31
EPS
N/A
N/A
Revenue
N/A
$4,822,272.00
Revenue This Year
$85.26
N/A
Revenue Next Year
$6.14
$220.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
97.62
52 Week Low
$7.31
$4.64
52 Week High
$10.38
$20.56

Technical Indicators

Market Signals
Indicator
BCBP
CRBP
Relative Strength Index (RSI) 53.99 56.49
Support Level $7.54 $8.39
Resistance Level $8.62 $9.51
Average True Range (ATR) 0.27 0.48
MACD -0.02 0.13
Stochastic Oscillator 55.32 82.89

Price Performance

Historical Comparison
BCBP
CRBP

About BCBP BCB Bancorp Inc. (NJ)

BCB Bancorp Inc is a bank holding company. The company offers loans, including commercial and multi-family real estate loans, home equity loans, construction loans, consumer loans, and commercial business loans; FDIC-insured deposit products, such as savings and club accounts, interest and non-interest bearing demand accounts, money market accounts, certificates of deposit and individual retirement accounts, and retail and commercial banking services, including wire transfers, money orders, safe deposit boxes, a night depository, debit cards, online banking, gift cards, fraud detection and automated teller services.

About CRBP Corbus Pharmaceuticals Holdings Inc.

Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

Share on Social Networks: